These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4985704)

  • 1. [Prognostic and therapeutic criteria in neonatal hyperbilirubinemia with and without isoimmunization. Personal cases].
    Gandolfo Caramello MT; Martinetto G
    Minerva Pediatr; 1968 Aug; 20(32):1606-15. PubMed ID: 4985704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 3. [OUR THERAPEUTIC EXPERIENCE WITH EXCHANGE TRANSFUSION IN GRAVE JAUNDICE OF THE NEWBORN].
    MAZZOLA G
    Pediatria (Napoli); 1964 Aug; 72():689-98. PubMed ID: 14190799
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pecularities of the rule of ABO transfusion compatibility in the neonatal period].
    Sender A; Maigret P; Poulain M; Boeswillwald M; Lepage F
    Ann Med Interne (Paris); 1971 Dec; 122(12):1263-6. PubMed ID: 5004914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neonatal hemolytic disease. I. Diagnostic, prognostic and therapeutic considerations in 45 cases of neonatal disease caused by Rh factor isoimmunization].
    Saggese V; De Marco A; Polito P
    Riv Clin Pediatr; 1967 Jan; 79(1):11-22. PubMed ID: 4970151
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE DEVELOPMENT OF THROMBOCYTE COUNT FOLLOWING EXCHANGE TRANSFUSION IN INFANCY].
    DUX E; KOVACS Z; PATAKI L
    Orv Hetil; 1963 Sep; 104():1641-5. PubMed ID: 14054562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical and hematometric effects of exchange transfusion in isoimmunized neonates].
    Jurfest-Ceccon ME; de Albuquerque Diniz EM; de Araujo-Ramos JL; Costa-Vaz FA
    Bol Med Hosp Infant Mex; 1993 Mar; 50(3):167-76. PubMed ID: 8442881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal hemolytic disease. II. Diagnostic, prognostic and therapeutic considerations on 24 cases of neonatal hemolytic disease caused by ABO factor isoimmunization].
    Saggese V; Di Marco A; Polito P
    Riv Clin Pediatr; 1967 Jan; 79(1):23-32. PubMed ID: 5628068
    [No Abstract]   [Full Text] [Related]  

  • 9. [Haptoglobin and bilirubin kinetics during exchange transfusion in the newborn].
    Giebelmann R; Faust G; Zöllner H; Hessel D
    Dtsch Gesundheitsw; 1970 Jun; 25(22):1042-4. PubMed ID: 5002410
    [No Abstract]   [Full Text] [Related]  

  • 10. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Penicillamine D therapy of hyperbilirubinemia in newborn infants. Preliminary report].
    Lakatos L; Kövér B
    Orv Hetil; 1974 Feb; 115(6):307-11. PubMed ID: 4209565
    [No Abstract]   [Full Text] [Related]  

  • 12. [Exchange transfusion and splenectomy for hyperbilirubinemia caused by hereditary spherocytosis in the neonatal period].
    Reddemann H
    Z Kinderheilkd; 1967; 100(3):192-204. PubMed ID: 5595863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bilirubin and brain injury].
    Takahashi S; Wada M; Kimura E
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):455-61. PubMed ID: 11057283
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acid-base quilibrium, lactate and pyruvate, electrolytes during exchange transfusion performed with citrated blood].
    Duc G; de Muralt G
    Schweiz Med Wochenschr; 1967 Sep; 97(36):1176-9. PubMed ID: 4969768
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the albumin binding capacity in Rh immunization. Practical and theoretical interest. Personal experience.
    Streiff F; Vigneron C; Pierson M; Olive D; Genetet B; Pierron N
    Ann Ostet Ginecol Med Perinat; 1971 Sep; 92(9):613-4. PubMed ID: 5003296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aspects of ABO blood group incompatibility in the pre- and postnatal periods].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(4):322-8. PubMed ID: 6774626
    [No Abstract]   [Full Text] [Related]  

  • 18. [Maternal blood group 0 as a risk factor of neonatal hyperbilirubinemia requiring treatment].
    Heier HE; Fugelseth D; Lindemann R; Qvigstad E
    Tidsskr Nor Laegeforen; 1996 Jan; 116(1):34-6. PubMed ID: 8553332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFFECT OF EXCHANGE TRANSFUSION ON THE PROTEIN-BOUND IODINE IN THE NEWBORN INFANT.
    PELTONEN T; HIRVONEN L
    Ann Acad Sci Fenn A; 1964; 106():SUPPL 14:1-7. PubMed ID: 14188060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of blood exchange in the newborn].
    Chmelo K; Bendík I
    Cesk Gynekol; 1969 Oct; 34(8):490-3. PubMed ID: 4982154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.